The HIV-1 sequences (above) are from India and Kenya.
Vandongen makes interesting connections with HIV-1:
1 Nov 2022
'....appears to cloak the novel coronavirus from white blood cells, a characteristic also found in HIV-1.'
Vandongen refers to this study, and ref #52 therein:
Despite claims from prominent scientists that SARS-CoV-2 indubitably emerged naturally, the etiology of this novel coronavirus remains a pressing and open question: Without knowing the true nature of a disease, it is impossible for clinicians to appropriately shape their care, for policy-makers...
pubmed.ncbi.nlm.nih.gov
'Ref #52 (Guandong) : 'The Orf8 protein of SARS-Cov-2 mediates immune evasion through potently downregulating MHC-1....In addition, Orf8 showed strong co-localization with calnexin+ ER and LAMP1+ lysosome.'
We'll return to LAMP1 later.
Vandongen continues @ 1Nov: 'And the second preprint identifies a region of the spike-protein gene found in no other bat-borne coronavirus that is nearly identical to superantigenic and neurotoxic motifs found in some bacteria, which may contribute to the immune overreaction that leads to the Kawasaki-like multisystem inflammatory syndrome in children, and cytokine storms in adults.'
Vandongen is referring to this report:
Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19 is a newly recognized condition in children with recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. These children and adult patients with severe hyperinflammation present with a...
pubmed.ncbi.nlm.nih.gov
MIS-C and Kawasaki disease was posted to USMB on 8 Jul 2020:
Post #700
At Pubmed, there is only one entry for chloroquine use in the suspected COVID-19 intermediate host, Chrysemys: (1985) Chrysemys / Thyroid / Chloroquine https://www.ncbi.nlm.nih.gov/pubmed/3905504 '....chloroquine or bacitracin inhibited the degradation activity.'
www.usmessageboard.com
'.....Fortunately, doctors and researchers have been racing to understand the mysterious syndrome, which can cause life-threatening complications, including coronary artery aneurysms and toxic shock syndrome.
"We don't know the risk factors - which kids get this and which kids don't, it's hard to know. Especially because most have been previously healthy," said Dr. Nadine Choueiter, a pediatric cardiologist and Director of the Kawasaki Disease Program at the Children's Hospital at Montefiore in New York City.'